CW Advisors LLC Increases Stock Holdings in Cigna Group $CI

CW Advisors LLC increased its holdings in Cigna Group (NYSE:CI) by 64.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,675 shares of the health services provider’s stock after buying an additional 13,535 shares during the period. CW Advisors LLC’s holdings in Cigna Group were worth $11,463,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CI. Flaharty Asset Management LLC purchased a new stake in shares of Cigna Group in the first quarter valued at about $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group during the 1st quarter worth approximately $29,000. Solstein Capital LLC purchased a new stake in Cigna Group in the 2nd quarter valued at approximately $29,000. Activest Wealth Management grew its holdings in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after buying an additional 72 shares during the last quarter. Finally, Chilton Capital Management LLC purchased a new position in Cigna Group during the second quarter worth $30,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CI. Raymond James Financial restated a “strong-buy” rating on shares of Cigna Group in a research report on Monday, November 3rd. Leerink Partners reduced their target price on shares of Cigna Group from $300.00 to $270.00 in a report on Friday, October 31st. Zacks Research cut shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research note on Monday, November 3rd. Guggenheim reissued a “buy” rating and issued a $318.00 price objective on shares of Cigna Group in a research report on Tuesday. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research note on Monday. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $334.45.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This represents a 9.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The stock was purchased at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.70% of the company’s stock.

Cigna Group Trading Down 0.9%

NYSE CI opened at $267.98 on Friday. The company has a market cap of $71.59 billion, a P/E ratio of 11.82, a P/E/G ratio of 0.98 and a beta of 0.26. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. The company has a 50-day moving average of $283.63 and a 200-day moving average of $296.31.

Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. During the same period in the previous year, the firm earned $7.51 earnings per share. Cigna Group’s revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 26.64%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.